| Synonyms: | |
| Status: | Phase 1 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 455J2479FY |
| InChI Key | HPODOLXTMDHLLC-QGZVFWFLSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C27H33F3N4O3 |
| Molecular Weight | 518.58 |
| AlogP | 4.72 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 7.0 |
| Polar Surface Area | 79.36 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 37.0 |
| Primary Target | |
|---|---|
| enhancer of zeste 2 polycomb repressive complex 2 subunit |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 1
Cytochrome P450 family 1A
Cytochrome P450 1A2
|
- | - | - | - | 15 | |
|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2C
Cytochrome P450 2C8
|
- | - | - | - | 41 | |
|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2C
Cytochrome P450 2C9
|
- | - | - | - | 11 | |
|
Enzyme
Cytochrome P450
Cytochrome P450 family 2
Cytochrome P450 family 2D
Cytochrome P450 2D6
|
- | - | - | - | 10 | |
|
Enzyme
Cytochrome P450
Cytochrome P450 family 3
Cytochrome P450 family 3A
Cytochrome P450 3A4
|
- | - | - | - | 0 | |
|
Epigenetic regulator
Writer
Protein methyltransferase
|
28-32 | 2-3 | - | - | - | |
|
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | 21300 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Lymphoma, Follicular | 1 | D008224 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 1 | D064129 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 1621862-70-1 |
| ChEMBL | CHEMBL4297463 |
| DrugBank | DB14581 |
| FDA SRS | 455J2479FY |
| Guide to Pharmacology | 9115 |
| SureChEMBL | SCHEMBL17329268 |
| ZINC | ZINC000220982768 |